Persuasive Essay On Cancer Cost

But instead of finding ways to prevent or cure cancer they pour all their funding into treating cancer. Why would they want to get rid of this money machine? The “Cancer Machine” rakes in loads of cash from chemotherapy drugs, radiotherapy, diagnostic procedures, and surgeries. The typical cancer patient will spend around 50,000 dollars fighting the disease, but if the cancer industry allows a cure then their patient base goes away along with all their funding. It makes more sense for them to keep their patients alive, but sick and coming back for more. A crazy statistic points out that “two out of three cancer patients will be dead within five years after receiving all or part of the standard cancer treatment…” It makes you wonder as to how well is this “cancer treatment”

The pharmaceutical industry is one of the most powerful and greedy industries in our country, with a goal to make as large a profit as possible, at the expense of the sick.

In an article written by oncologist Lacie Glover, her concern was about the rising cost of cancer treatment, newly approved cancer drug costs of an average of $10,000 per month, and therapy costs averaging $30,000 per month. A patient typically pays 20-30% out of pocket for drugs. Therefore, the year’s average cost of new cancer medications would $26,000-$36,000, in addition to their health insurance premiums. If you wonder why insurance premiums are constantly on the rise, reflecting on the illnesses and costs to treat them.

Cancer is one of the leading cause of death in Australia and has a considerable social and economic influence on individuals, families and the community. Statistics shows that Australia has third highest cancer rate approximately 323 people being diagnosed per 100,000 in the world. (Begg & etal, 2007, pg.116). According to the recent disease study in burden of disease by WHO and Global Burden of disease study 2012, the findings of study showed 16% and 19% of the total disease burden in Australia (Moore & et al, 2007 pg.88)). Cancer is the sixth most expensive chronic disease due to the high expenditure of treatment and management compared to other chronic disease. It has been further described that approximately $4.5 billion were spent on cancer in 2008-09, accounting for 7% of total healthcare expenditure on chronic disease (Australian Institute of Health and Welfare, 2013b, p.7) and 79% of total expenditure that spent on cancer patients who were admitted in hospital which is 20% more than the same expenditure that was spent on all

“Lets not call cancer patients as patients, they are cancer fighters. They are brave hearts” - Vikrmn, Gura. Nowadays, you hear more and more people getting cancer(13). It is a stress that many people worry about. You worry if one of your parents will get it. You pray your children don't’ get it. It’s a constant worry. You watch television and you can get this horrible monster from microwaving your food, drinking bottled water, carrying your phone in your pocket, using deodorant, coloring your hair and much more. Finding a cure for cancer would be a prayer answered for many.

Anyone who has purchased prescription medications has probably wondered why they cost so much, and rightfully so. Medication prices in the United States have been on a steady increase for decades, however, prices have been drastically increasing as of recent. Pharmaceutical companies have tried to justify these price increases due to the demand, the high cost of research, and the high costs of development and approval. Notwithstanding, the extent to which the prices have increased is not justifiable. Americans should be against these high medication prices and take action because pharmaceutical companies are taking advantage of our healthcare system in order to capitalize from the sick. In order shed some light on this issue, the magnitude, scope, and consequences of these prices must be examined.

Thesis: An examination of the case study New Protocol: How Drug’s Rebirth as Treatment for Cancer Fueled Price Rises relies heavily on a keen understanding of the social and economic implications of a capitalist system, and once taken into account it is clear that Celgene Corp. is justified in raising prices based on the business market philosophies asserted by

The journalist Nadia Kounang further explains the differences between what the U.S pays on drugs and other similar developed countries, in the article Why pharmaceuticals are cheaper abroad. Kounang displays how much American need to pay for Gleevec (cancer medication) which is $6,214 (per month/per customer) whereas in Canada patients only have to pay $1,141 and in the U.K $2,697 (Kounang 1). These prices are the result of different organizations setting different price ranges with drug companies (U.S.A), and these enables American insurance companies to take advantage of it (Kounang 1). While in other countries there are not as many organizations, so this helps to set a deal of a price that benefit both the drug company and consumers (Kounang). Strictly speaking, by having these different medical insurance companies it has made it difficult for patients to afford their medication because there is no singular organization that can set drug price ranges with pharmaceuticals, while in other countries they don’t a variety of different medical insurances which enables the country to provide treatments that its citizens can afford. Thereby, if the government does not fully cooperates with other medical insurances, lowering the cost of medication will be difficult without affecting research and development. And as a result people who can not afford them will still struggle to obtain their required prescriptions.

The high prices set by pharmaceutical companies for drugs allows the companies to continue researching, developing, and producing new drugs. As new diseases are discovered, new medications must be discovered in order to treat them.

Background: Americans pay the highest prices for prescription drugs in the world. Drug costs increased 12.6 percent last year, more than double the rise in overall medical costs. A new Kaiser Health poll shows that most Americans think prescription drug costs in this country are unreasonable, and that drug companies put profits before people.1 Take the example of albendazole which is broad spectrum anti-parasitic drug. In late 2010, the listed average wholesale price for albendazole was $5.92 per typical daily dose in the United States and less than $1 per typical daily dose overseas. By 2013, the listed typical daily dose price for USA market had increased to $119.58. Medicaid data show that spending on albendazole increased from less than $100,000 per year in 2008, when the average cost was $36.10 per prescription, to more than $7.5 million in 2013, when the average cost was $241.30 per prescription2. Albendazole is a very basic medicine but if we take the case of oncology medicines we are going to realize that oncology drugs have become synonymous with extremely high cost. The average cancer drug price for approximately 1 year of therapy was less than 10,000 per year in 2010 and had increased to $30,000 to $50,000 by 2005. In 2012, 12 of the 13 new drugs approved for cancer indications were priced above $100,000 per year of therapy. With typical out-of-pocket expenses of 20% to 30%, the financial burden would be $20,000 to 30,000 a year, nearly half of the average annual

For many types of cancers, we have been using the same base drug (first line treatment) for ten years or even longer. As companies find new drugs to fight the cancers, they hope that it will be the miracle drug that will eradicate the cancer, but it usually isn’t. When they reach this conclusion, instead of returning to the chalkboard and continuing to work to improve the drug, they put the drug on the market as is, and hope it will achieve something. Not only are they putting these drugs on the market but they put price tags on them that would bankrupt anyone without some sort of third party payer. The combination of all of these drugs make up what doctors

I am primarily concerned about the impact that the excessive costs will be a burden on the patients. According to the PA House Republican Caucus, the cost of these oral chemotherapy medications accumulate to an outstanding $1,400-$3,500 out of pocket costs a month! Cancer patients are facing these cost burdens each day and without the bill being passed, patients are choosing to succumb to their disease, abandon treatment, and give up the fight in order to save their family from falling into debt due to the ongoing co-pays. Patients are genuinely choosing death instead of encouraging life because of these unaffordable pills. As a Community Health Educator, one of my most

Cancer is figured to be the second leading causes of morbidity and mortality worldwide. With approximately 14 million new cases and 8.2 million cancer related deaths in 2012, alone .Why are so many people stuck suffering with this deadly disease? Millions of dollars have been invested into cancer research, yet there is no cure. Are these pharmaceutical companies focus on finding a cure for cancer or concentrating on elongated treatments in order to lengthen their pockets? We must first understand that cancer is big business earning huge profits. Nonetheless, the cancer industry is spending virtually zilch of its multi-billion dollar resources on effective prevention strategies, like dietary guidelines, exercise, natural remedies and herbs proven to cure cancer. Instead, it pours its money into treating cancer, not preventing or allaying it.

Cancer. We all know someone who has suffered from it or has passed away because of it. Cancer now affects one in every three people, and is the second highest cause of death in the United States. For decades, the medical community has been on the hunt for a cure for cancer, and have been subjected to intense ridicule from the public because of a lack of progression toward a possible cure. In recent years, many scientists, doctors, researchers, and the general public have come to believe that the cure for cancer is being suppressed because of this lack of progress. Those who say it is suppressed claim that the drugs used to treat cancer actually cause cancer, making a patient sicker and sicker. As a result, the patients are forced to spend

Today in the world there are many different types of reproductive cancers. A reproductive cancer I’m going to be writing about is Breast cancer. Yes, its Breast Cancer. According to American Cancer Society (2017) Breast cancer is “Breast cancer starts when cells in the breast begin to grow out of control. These cells usually form a tumor that can often be seen on an x-ray or felt as a lump. The tumor is malignant (cancer) if the cells can grow into (invade)surrounding tissues or spread (metastasize) to distant areas of the body. Breast cancer occurs almost entirely in women, but men can get cancer too (pg.1). Although Breast cancer first start in the breast, it can also start from other places surrounding that tissue or area.